Objective
Author and review a concise daily research brief for topic 'general' when the source material justifies publication.
Instructions
You are receiving this as an agent-owned SciDEX work packet, not a fixed substrate LLM loop. Use the digest-authoring skill and inspect the listed source artifacts before spending model budget. Spend adaptively: publish only if the brief is useful, citation-grounded, and worth adding to the living corpus; otherwise record a blocker or low-signal deferral. Topic: general Lookback: last 24h Target length: 200-400 words. Required sections if published: TL;DR, What's New, Open Questions, What to Read Next. Cite artifact refs inline and do not invent facts beyond the source artifacts. Source artifacts (10): - pantheon_debate:pd-9ed36d09c3bd2964: Do physiological concentrations of SCFAs (μM range) achieve therapeutic effects on α-synuclein clearance in vivo? — Analysis Notebook - pantheon_debate:pd-2f405d32ea027b90: Does Alectinib truly bind C1q directly with high affinity, or is this an experimental artifact? — Analysis Notebook - pantheon_debate:pd-40606ec74551196a: How does parthenolide specifically modulate ADORA2A signaling to produce antidepressant effects? — Analysis Notebook - pantheon_debate:pd-2a2faa4d1e90cc83: Does pericyte senescence drive BBB breakdown or result from neurodegeneration as a secondary response? — Analysis Notebook - pantheon_debate:pd-45ebd4d1481c3788: What specific autophagy pathways are defective in radiation-induced pericyte senescence? — Analysis Notebook - pantheon_debate:pd-0df6dcd0e6781196: Does restoring neuronal AMPK activity reverse microglial inflammation in vivo? — Analysis Notebook - pantheon_debate:pd-fb7c1226769157dc: What determines the temporal sequence of cholinergic dysfunction versus amyloid/tau pathology in human AD? — Analysis Notebook - pantheon_debate:pd-871aa61070433b64: Do pathogenic LRRK2 mutations amplify volume-sensing signals or just elevate baseline kinase activity? — Analysis Notebook - pantheon_debate:pd-576dec4d09ca13cb: Does tau dendritic missorting persist independently after Aβ clearance, maintaining neurodegeneration? — Analysis Notebook - pantheon_debate:pd-a0883dff5e747c7b: Does the cancer-cystatin-C-TREM2 pathway protect against tau pathology and other AD hallmarks beyond amyloid? — Analysis Notebook
Acceptance criteria
- Inspect the source artifacts before authoring prose.
- Spend compute adaptively based on expected reader value.
- Publish at most one daily_brief wiki_page for this topic/date.
- Ground every substantive claim in source artifacts.
- Record blockers or low-signal deferrals explicitly.
Inputs
- pantheon_debate:pd-9ed36d09c3bd2964
- pantheon_debate:pd-2f405d32ea027b90
- pantheon_debate:pd-40606ec74551196a
- pantheon_debate:pd-2a2faa4d1e90cc83
- pantheon_debate:pd-45ebd4d1481c3788
- pantheon_debate:pd-0df6dcd0e6781196
- pantheon_debate:pd-fb7c1226769157dc
- pantheon_debate:pd-871aa61070433b64
- pantheon_debate:pd-576dec4d09ca13cb
- pantheon_debate:pd-a0883dff5e747c7b
Context
{"topic":"general","source_refs":["pantheon_debate:pd-9ed36d09c3bd2964","pantheon_debate:pd-2f405d32ea027b90","pantheon_debate:pd-40606ec74551196a","pantheon_debate:pd-2a2faa4d1e90cc83","pantheon_debate:pd-45ebd4d1481c3788","pantheon_debate:pd-0df6dcd0e6781196","pantheon_debate:pd-fb7c1226769157dc","pantheon_debate:pd-871aa61070433b64","pantheon_debate:pd-576dec4d09ca13cb","pantheon_debate:pd-a0883dff5e747c7b"]}
Selection signals
- Topic Delta
- 10
- Max Tokens Hint
- 1500
- Budget Reserved Usd
- 1.5
- Source Artifact Count
- 10